Plants popularly used for loosing weight purposes in Porto Alegre, South Brazil.

Depto. de Botanica, Instituto de Biociencias, Universidade Federal do Rio Grande do Sul. Av. Bento Gonçalves 9500, Prédio 43433, Campus do Vale, 91501-970 Porto Alegre, RS, Brazil.
Journal of Ethnopharmacology (Impact Factor: 2.94). 02/2007; 109(1):60-71. DOI: 10.1016/j.jep.2006.07.003
Source: PubMed

ABSTRACT In this study, 14 herbalists (herb sellers) were interviewed about popular use of plants with weight loss purpose in Porto Alegre, a South Brazil city. For all identified species, scientific data were reviewed aiming to establish a correlation between popular use and biological properties. Seventy-eight samples were reported as having weigh loss properties. These samples come from 23 species and Asteraceae encompasses the greatest number of representatives. The greatest number of herbalist's citations was Baccharis articulata. The majority of plants have traditional use in Brazil but none is explicitly cited for loosing weight purposes. The pharmacological data are mainly from animal and in vitro studies and do not straight related to obesity. Only Ilex paraguariensis presents clinical data of efficacy in the treatment of obesity. Seven species present pre-clinical data that indicate a potential role in the control of certain conditions which are associated with obesity, such as hyperlipidemia (Campomanesia xanthocarpa, Cuphea carthagenensis, Cynara scolymus, Hibiscus sabdariffa, Ilex paraguariensis) and high levels of blood glucose (Achyrocline satureioides, Baccharis trimera, Campomanesia xanthocarpa). In conclusion, scientific data found are insufficient to guarantee the efficacy and safety of these plants for treating obesity. However, some of them present activities which could be useful to treat certain obesity comorbidities and deserve further studies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Constituents of the essential oils from the aerial parts of Baccharis articulata (Ba), Baccharis genistelloides subsp. crispa (Bc), Baccharis dracunculifolia (Bd) and Baccharis gaudichaudiana (Bg), Asteraceae, obtained by hydrodistillation and analyzed by gas chromatography (GC)/mass spectrometry (MS) and GC/flame ionization detector (FID) were identified. Also, their anti-inflammatory potential, focusing their immunomodulatory activity using flow cytometric analyses and AgNOR profiles, and anti-chemotactic properties, conducted using a Boyden’s chamber system, were investigated. Fifty-eight compounds were characterized, representing 66.7% of the total components detected. The major constituents identified were spathulenol (in Ba, Bd and Bg), τ-gurjunene (in Bg) and palustrol (in Ba). The data presented herein showed that the Baccharis essential oils included in this study were inert for human resting lymphocytes, while all but Ba’s inhibited significantly the proliferation of their phytohemagglutinin-stimulated counterparts. In addition, only the essential oil of Bd inhibited significantly the casein-induced human granulocyte chemotaxis. This is the first report concerning the potential diversity of anti-inflammatory activities of the essential oils of Baccharis plants on human cells responsible for the host defense mechanisms that may be of benefit in intervening with immune disorders associated or not with inflammatory conditions.
    Journal of Essential Oil Research 12/2012; 24(6):561-570. DOI:10.1080/10412905.2012.728081 · 0.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hibiscus sabdariffa L. (Hs, roselle; Malvaceae) has been used traditionally as a food, in herbal drinks, in hot and cold beverages, as a flavouring agent in the food industry and as a herbal medicine. In vitro and in vivo studies as well as some clinical trials provide some evidence mostly for phytochemically poorly characterised Hs extracts. Extracts showed antibacterial, anti-oxidant, nephro- and hepato-protective, renal/diuretic effect, effects on lipid metabolism (anti-cholesterol), anti-diabetic and anti-hypertensive effects among others. This might be linked to strong antioxidant activities, inhibition of α-glucosidase and α-amylase, inhibition of angiotensin-converting enzymes (ACE), and direct vaso-relaxant effect or calcium channel modulation. Phenolic acids (esp. protocatechuic acid), organic acid (hydroxycitric acid and hibiscus acid) and anthocyanins (delphinidin-3-sambubioside and cyanidin-3-sambubioside) are likely to contribute to the reported effects. More well designed controlled clinical trials are needed which use phytochemically characterised preparations. Hs has an excellent safety and tolerability record.
    Food Chemistry 12/2014; 165. DOI:10.1016/j.foodchem.2014.05.002 · 3.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study evaluated the in vivo potential antihypertensive effect of hydroalcoholic extract of Syzygium cumini leaves (HESC) in normotensive Wistar rats and in spontaneously hypertensive rats (SHR), as well as its in vitro effect on the vascular reactivity of resistance arteries. The hypotensive effect caused by intravenous infusion of HESC (0.01–4.0 mg/kg) in anesthetized Wistar rats was dose-dependent and was partially inhibited by pretreatment with atropine sulfate. SHR received HESC (0.5 g/kg/day), orally, for 8 weeks and mean arterial pressure, heart rate, and vascular reactivity were evaluated. Daily oral administration of HESC resulted in a time-dependent blood pressure reduction in SHR, with a maximum reduction of 62%. In the endothelium-deprived superior mesenteric arteries rings the treatment with HESC reduced by 40% the maximum effect () of contraction induced by NE. The contractile response to calcium and NE of endothelium-deprived mesenteric rings isolated from untreated SHR was reduced in a concentration-dependent manner by HESC (0.1, 0.25, and 0.5 mg/mL). This study demonstrated that Syzygium cumini reduces the blood pressure and heart rate of SHR and that this antihypertensive effect is probably due to the inhibition of arterial tone and extracellular calcium influx.
    Evidence-based Complementary and Alternative Medicine 12/2014; 2014:7. DOI:10.1155/2014/605452 · 1.72 Impact Factor